drugset / Trial / NCT07039929
Study to Assess the Safety, Tolerability, and Pharmacokinetics of INCB000631 When Administered Orally to Healthy Adult Participants
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will be conducted to assess the safety, tolerability, and pharmacokinetics of INCB000631 when administered orally to healthy adult participants.
Timeline
- Start
- 2025-07-28
- Primary completion
- 2025-10-11
- Completion
- 2025-10-11
Outcome
Outcome not reported
Stopped (Business): “Strategic Business Decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | INCB000631 | Unknown | — | Oral |
Indications
No indication recorded.